TELA

TELA Bio, Inc. Common Stock

0.82

USD

+0.04

+5.13%

Nov 06, 15:59 UTC -5

Closed

After-Market

0.82

+0.01

+0.61%

TELA Bio, Inc. Common Stock (TELA) Profile

TELA Bio, Inc. Common Stock Profile

About

TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered in Malvern, Pennsylvania.

Info & Links

CEO

Antony Koblish

Headquarters

1 GREAT VALLEY PARKWAY, SUITE 24
MALVERN, PA 19355, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

150

TELA Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

37.24M

Enterprise Value

62.90M

Enterprise Value/EBITDA(ttm)

-1.91

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.45

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

68.33%

Operating Margin(ttm)

-50.66%

Profit Margin(ttm)

-51.92%

Return on Equity(ttm)

-1320.81%

Return on Invested Capital(ttm)

-86.80%

Return on Assets(ttm)

-59.39%

Income Statement

Revenue(ttm)

79.91M

Revenue Per Share(ttm)

1.78

Gross Profit(ttm)

54.57M

EBITDA(ttm)³

-33.01M

Net Income Available to Common(ttm)

-41.18M

Diluted EPS(ttm)

-0.77

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

-30.51%

S&P 500 52-Week Change

14.03%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

44.89M

Dividend Yield

0.00%

Float⁴

44.65M

% Held by Insiders

1.10%

% Held by Institutions

94.35%

Balance Sheet

Total Cash(mrq)

30.42M

Total Cash Per Share(mrq)

0.68

Total Debt(mrq)

56.08M

Total Debt/Equity(mrq)

-353.47%

Current Ratio(mrq)

2.99%

Quick Ratio(mrq)

2.38%

Book Value Per Share(mrq)

-0.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.36

Free Cash Flow(ytd)

-20.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.